Tag Archives: readies

Apple readies launch of $3,000 headset: Will it succeed where others have failed? – MarketWatch

  1. Apple readies launch of $3,000 headset: Will it succeed where others have failed? MarketWatch
  2. Apple may beat Samsung to the punch and unveil its mixed-reality headset in June SamMobile – Samsung news
  3. Reality Pro launch and pricing: Making sense of the speculation 9to5Mac
  4. Apple’s Reality Pro VR headset is the future, which is why you shouldn’t buy it iMore
  5. Will Apple’s MR Headset Be A Hit Or Flop? Munster Says This Is What Most Investors Expect – Microsoft (NASDAQ:MSFT), Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Meta Platforms (NASDAQ:META), Apple (NASDAQ:AAPL) Benzinga
  6. View Full Coverage on Google News

Read original article here

Russia-Ukraine war news: Moscow slams NATO’s expansion as Finland readies for membership – The Washington Post

  1. Russia-Ukraine war news: Moscow slams NATO’s expansion as Finland readies for membership The Washington Post
  2. Russia-Ukraine live news: Finland to join NATO in historic shift Al Jazeera English
  3. 🔴Live: Finland joins NATO as Russia says it may get ‘tough’ on hostile EU FRANCE 24 English
  4. Ukraine-Russia war latest: Ukraine intercepts wave of Russian drone strikes over key port city The Telegraph
  5. Sweden Summons Russia’s Ambassador Over ‘Legitimate Target’ Statement Radio Free Europe / Radio Liberty
  6. View Full Coverage on Google News

Read original article here

Travel curbs rack up as COVID-hit China readies reopening

  • China to drop quarantine for overseas visitors on Sunday
  • Greece joins nations imposing travel curbs on China
  • Travel rush, holidays could inflame virus outbreak

SHANGHAI/BEIJING, Jan 6 (Reuters) – More countries around the world are demanding that visitors from China take COVID tests, days before it drops border controls and ushers in an eagerly awaited return to travel for a population that has been largely stuck at home for three years.

From Sunday, China will end the requirement for inbound travellers to quarantine, the latest dismantling of its “zero-COVID” regime that began last month following historic protests against a suffocating series of mass lockdowns.

But the abrupt changes have exposed many of China’s 1.4 billion population to the virus for the first time, triggering an infection wave that is overwhelming some hospitals, emptying pharmacy shelves of medication and causing international alarm.

Greece, Germany and Sweden on Thursday joined more than a dozen countries to demand COVID tests from Chinese travellers, as the World Health Organisation said China’s official virus data was under-reporting the true extent of its outbreak.

Chinese officials and state media have struck a defiant tone, defending the handling of the outbreak, playing down the severity of the surge and denouncing foreign travel requirements for its residents.

Foreign Ministry spokesperson Mao Ning warned on Friday of possible reciprocal measures after the European Union recommended pre-departure testing for Chinese passengers.

“The EU should listen more to … rational voices and treat China’s epidemic prevention and control objectively and fairly,” Mao told a regular media briefing in Beijing.

The Global Times, a nationalistic tabloid published by the official People’s Daily, said in an editorial that some Western media and politicians “would never be satisfied” no matter what steps China takes.

The global aviation industry, battered by years of pandemic curbs, has also been critical of the decisions to impose testing on travellers from China. China will still require pre-departure testing for inbound travellers after Jan. 8.

HOSPITALS PACKED

Some Chinese citizens think the reopening has been too hasty.

“They should have taken a series of actions before opening up … and at the very least ensure that the pharmacies were well stocked,” a 70-year-old man who gave his surname as Zhao told Reuters in Shanghai.

China reported five new COVID deaths in the mainland for Thursday, bringing its official virus death toll to 5,264, one of the lowest in the world.

But that appeared to be at odds with the reality on the ground where funeral parlours are overwhelmed and hospitals are packed with elderly patients on respirators. In Shanghai, more than 200 taxi drivers are driving ambulances to meet demand for emergency services, the Shanghai Morning Post reported.

International health experts believe Beijing’s narrow definition of COVID deaths does not reflect a true toll that could rise to more than a million fatalities this year.

Investors are optimistic that China’s reopening can eventually reinvigorate a $17-trillion economy suffering its lowest growth in nearly half a century.

Those hopes, alongside policy measures to help revive its troubled property sector, lifted China’s yuan on Friday.

Meanwhile, both China’s blue-chip CSI300 Index (.CSI300) and the Shanghai Composite Index (.SSEC) have gained more than 2% in the first trading week of the year.

“While the re-opening is likely to be a bumpy affair amid surging COVID-19 cases and increasingly stretched health systems, our economists expect growth momentum across Asia to gather steam, led by China,” Herald van der Linde, HSBC’s head of equity strategy, Asia Pacific, said in a note.

SOUTHEAST ASIA OPEN

With the big Lunar New Year holidays late this month, the mainland is also set to open the border with its special administrative region of Hong Kong on Sunday, for the first time in three years.

Ferry services between the city and the gambling hub of Macau will resume on the same day.

Hong Kong’s Cathay Pacific Airways (0293.HK) said on Thursday it would more than double flights to mainland China. Flights to and from China remain at a tiny fraction of pre-COVID levels.

The WHO has warned that the holiday, which starts on Jan. 21 and usually brings the biggest human migration on the planet as people head home from cities to visit families in small towns and villages, could spark another infection wave in the absence of higher vaccination rates and other precautions.

Authorities expect 2.1 billion passenger trips, by road, rail, water and air, over the holiday, double last year’s 1.05 billion journeys during the same period.

The transport ministry has urged people to be cautious to minimise the risk of infection for elderly relatives, pregnant women and infants.

One region poised to be a major beneficiary of China’s opening is Southeast Asia, where countries have not demanded that Chinese visitors take COVID tests.

Except for airline wastewater testing by Malaysia and Thailand for the virus, the region’s 11 nations will treat Chinese travellers like any others.

As many as 76% of Chinese travel agencies ranked Southeast Asia as the top destination when outbound travel resumed, according to a recent survey by trade show ITB China.

Many people in China have taken to social media to announce their travel plans but some remain wary.

“You want to see the world, but the world might not want to see you,” wrote one WeChat user from Tianjin city.

Reporting by Brenda Goh in Shanghai, Bernard Orr, Eduardo Baptista, Martin Pollard and Liz Lee in Beijing, Farah Master in Hong Kong, and Xinghui Kok in Singapore; Writing by John Geddie and Greg Torode; Editing by Robert Birsel and Andrew Heavens

Our Standards: The Thomson Reuters Trust Principles.

Read original article here

China readies new COVID rules as investors cheer easing shift

  • New nationwide COVID rules due as soon as Wednesday – sources
  • Shift follows widespread demonstrations last month
  • Yuan firms, global markets rally on China hopes

HONG KONG/BEIJING, Dec 5 (Reuters) – China is set to announce the further easing of some of the world’s toughest COVID curbs as early as Wednesday, sources told Reuters, as investors cheered the prospect of a policy shift that follows widespread protests and mounting economic damage.

Three years into the pandemic, China’s zero-tolerance measures, from shut borders to frequent lockdowns, contrast sharply with the rest of the world, which has largely decided to live with the coronavirus.

The strict approach has battered the world’s second-largest economy, put mental strain on hundreds of millions and last month prompted the biggest show of public discontent in mainland China since President Xi Jinping took power in 2012.

Although last month’s protests largely subsided amid a heavy police presence across major cities, regional authorities have since cut back on lockdowns, quarantine rules and testing requirements to varying degrees. Top officials have also softened their tone on the dangers posed by the virus.

A new set of nationwide rules are due to be announced soon, two sources with knowledge of the matter said, paving the way for more coordinated easing.

Beijing is also weighing whether to scale down its management of the virus to reflect the less serious threat it poses as early as January, the sources added.

Analysts now predict China may drop border controls and re-open the economy sooner than expected next year.

“The risk of an earlier but managed exit has increased,” Goldman Sachs chief China economist Hui Shan said in a note on Monday, adding that the bank expected such a reopening from April. Other analysts expect a reopening in the second half.

But the patchy loosening over the past week has left some in China scared of being caught on the wrong side of fast-changing rules.

Yin, who lives in a small city near Beijing, said her in-laws had come down with a fever and she had a sore throat but they did not want to be tested for fear of being thrown into government quarantine.

“All we want is to recover at home,” she told Reuters, speaking on condition of anonymity.

The yuan jumped to its strongest level against the dollar since mid-September amid a broad market rally as investors hope the unwinding of pandemic curbs will brighten the outlook for global growth.

In another hopeful sign, a source at Apple supplier Foxconn (2317.TW) told Reuters the firm expected its COVID-hit Zhengzhou plant – the world’s biggest iPhone factory – to resume full production this month or early next.

Economic data underscored the damage done by the curbs, as services activity shrank to six-month lows in November.

CHANGING MESSAGE

Alongside the easing in different cities, Vice Premier Sun Chunlan, who oversees China’s COVID efforts, said last week the ability of the virus to cause disease was weakening.

That change in messaging aligns with the position held by many health officials around the world for more than a year.

In recent days, major cities across China have continued loosening measures.

Among them, the eastern city of Nanjing dropped the need of a COVID test to use public transport. So did Beijing, though entry to many offices in the capital still requires negative tests.

“I can’t feel a very noticeable change yet,” said Randle Li, 25, a marketing professional in Beijing. Li said his firm still required him to test every day to go to the office.

Elsewhere, as testing requirements have eased, official figures of new infections have also dropped.

Hu Xijin, a prominent commentator and former editor-in-chief of state-run tabloid Global Times, said in a blog post that some official tallies were likely underreporting the spread of the virus because of lower testing rates.

While last week’s protests have died down, frustration can still boil over, as events in the central city of Wuhan, where the virus first emerged in late 2019, showed this weekend.

On Saturday, people pushed down barriers in an apparent attempt to break out of a lockdown at a garment industrial park, video clips posted on Twitter showed.

Then on Sunday, dozens of students stood in the rain outside a university in the city demanding greater “transparency” in the school’s COVID policies, other videos showed.

Reuters was able to verify that the incidents happened in Wuhan.

Reporting by Ryan Woo, Bernard Orr and Martin Quin Pollard in Beijing and Julie Zhu and Kevin Huang in Hong Kong; Writing by John Geddie; Editing by Clarence Fernandez

Our Standards: The Thomson Reuters Trust Principles.

Read original article here

War With Russia Enters New Phase as Ukraine Readies Southern Counterblow

After months of Russian forces making painfully slow gains in Ukraine’s east, the focus of the war is moving to the south, where a potentially decisive phase of the conflict will play out.

Ukraine has used long-range artillery and rocket systems, including the American M142 Himars, to halt Russia’s grinding advances in the east, destroying ammunition dumps, command-and-control centers and air-defense systems that appear to have limited Moscow’s ability to supply its front lines. Now, with the help of these Western weapons, Ukraine says it is mounting a counteroffensive to take back the southern port city of Kherson.

Russia continues its bombardment of cities across Ukraine including in the early hours of Sunday, when it launched an assault on the port of Mykolaiv, killing a prominent businessman. But for Ukraine, Kherson is an important strategic objective as the largest population center occupied by the Russians and the first city to fall. As a port, it is economically important to the Ukrainians and taking it back would deny Russian forces access to the southern coast toward Odessa.

Mick Ryan, a military strategist and retired major general in the Australian army, said the offensive will force Russia to make hard decisions about keeping troops in the Donbas or moving them south to protect Kherson.

If the Ukrainians retake the city, he said, they could be in a position to threaten Russia’s main Black Sea naval base, 150 miles away, at Sevastopol.

The Ukrainian effort to retake Kherson represents a significant development in the conflict, said Gen. Ryan. “If the Ukrainians can take that back, that will be a turning point,” he said. “But we’re not at a turning point yet.”

Ukrainian soldiers fire a 155mm shell from a Western-supplied M777 Howitzer at a Russian military position in Ukraine’s Kharkiv region, July 23.



Photo:

Joseph Sywenkyj for The Wall Street Journal

Eliot Cohen, a military historian and strategist with the bipartisan policy research group the Center for Strategic and International Studies in Washington, said Kherson carried great symbolic importance.

“Taking back the original city that the Russians took without much effort in the beginning, would be psychologically very significant,” he said. It would be a bigger deal than either Ukraine’s recapture of Snake Island in June or the sinking of Russia’s flagship, the Moskva, in April.

Military offensives are more challenging than defensive operations. Analysts caution that Ukraine shouldn’t – and likely won’t – rush into the fight in the south because it must continue to check Russian advances in the east. But demonstrating that it can retake ground in the south would provide an important victory for Ukrainian morale and show its backers, particularly those in Europe as the continent faces a tough winter with likely energy shortages, that their support is yielding results on the ground.

If Ukraine’s push to dislodge Russians from Kherson fails or falters, however, it could weaken support for Kyiv’s fight in some Western capitals. Ukrainians are likely to continue fighting whatever happens, but an unsuccessful campaign could prompt more calls for a negotiated settlement, particularly from parts of Western Europe facing reduced flows of Russian natural gas.

U.S. officials say Ukrainian forces are advancing in the south, and public assessments from British defense intelligence suggest the counteroffensive in Kherson is gathering momentum. The British intelligence said Thursday that Ukrainian forces have likely established a bridgehead south of the Ingulets River, which forms the northern boundary of the Kherson region, and have damaged at least three bridges that Russia uses to deliver supplies to the area. One—the 1,100-yard Antonivsky bridge near Kherson city—is now probably unusable.

This has exposed Russia’s 49th Army, stationed on the west bank of the Dnipro River, and has cut off Kherson city from other occupied territories, the British intelligence said. On Saturday, they said Russian forces were highly likely to have established two pontoon bridges and a ferry system to compensate for the bridge damage.

A road bridge across the Dnipro River was damaged by Ukrainian missiles July 20.



Photo:

Sergei Bobylev/WAASS/Zuma Press

This phase of the war will look different from the first one, when Moscow unsuccessfully mounted an effort to strike at Kyiv and topple the government of President

Volodymyr Zelensky,

and the second that continues in the east, where grueling exchanges of artillery fire have yielded modest advantages for Russian forces at great cost.

Mr. Cohen says this phase will likely have parallels with what happened in the last year of World War I, when the Germans on the one side and the British and Australians on the other sought to “break in” past the front lines, exploit weakness and infiltrate forces.

This requires “meticulously planned operations, which take one bite at a time out of the enemy’s front line. And then you move artillery forward, you consolidate your position, let them counterattack if they want to, and then you take another bite,” he said.

Analysts point out that this phase won’t depend on artillery alone. Konrad Muzyka, president of Rochan Consulting, military analysts based in Gdansk, Poland, said, “Himars cripple Russia’s ability to conduct offensive operations, but they won’t force the Russians to leave Ukraine. For that you need manpower and armor.”

This brings in the big unknown: “We don’t know what the structure of the Ukrainian army is, we don’t know its number of troops or the state of their morale,” he said. Ukraine has lost thousands of soldiers in recent months and many good leaders.

Chris Dougherty, a former U.S. Defense Department strategist now at the Center for a New American Security, said that, despite all the materiel the West has given to Ukraine, it probably still lacks the equipment and trained forces to retake ground successfully and quickly.

“The worry I have is we give advanced equipment to the Ukrainians and they use it to stop the bleeding,” he said. “That makes sense if you’re bleeding to death. But what’s the next thing you do?” He said Russia has been unable to capitalize on its massive artillery blitzes to take significant ground, and Ukraine risks falling into the same trap.

Ukrainian soldiers on the front line near Izyum.



Photo:

Manu Brabo for The Wall Street Journal

Mr. Dougherty said he doubts Ukrainian forces can take ground in the east, where Russian forces are well dug-in, but thinks they can do it around Kherson or other areas in the south, where operations by partisans have already been hitting Russian targets.

“They have to make sure the Russians can’t rapidly reinforce from another area,” he said. “And the Ukrainians have to make sure they take advantage of what they have – partisans and intelligence inside Kherson.”

“The Ukrainians have to find a way to hit weak points in the Russian line and hit them in the rear of their line. Nothing panics an army like knowing their line is getting hit in the rear,” he said.

Some military analysts said that given Western military resources and hardware, economic aid and critical intelligence assessments about Russian military movements, the balance in the south is shifting to the Ukrainians.

Russia has already lost tens of thousands of soldiers killed and injured in its efforts so far, and analysts suspect many units are on the brink of exhaustion. They will be looking out for indications that the Russian army is becoming brittle and signs of mutiny, desertion, combat refusal and surrenders. Meanwhile, evidence is growing that the Russian economy is hurting from Western-led sanctions.

“My view is the momentum is sort of gradually swinging to Ukrainians,” said Mr. Cohen. “In war, unpredictable things happen. People make mistakes. All that… Nothing is a certainty. But at the moment, would I rather have the Ukrainian hand to play with or the Russian hand to play? I would rather have the Ukrainian hand, provided that the West continues to pour military support and some economic support in there.”

Russian Navy members patrol in front of a headquarter of Russia’s Black Sea Fleet in Sevastopol.



Photo:

Agence France-Presse/Getty Images

Write to Stephen Fidler at stephen.fidler@wsj.com and Daniel Michaels at daniel.michaels@wsj.com

Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Read original article here

Another universal coronavirus vaccine readies for human trials

As scientists frantically chase a rapidly mutating SARS-CoV-2 virus by trying to update current COVID vaccines to better target circulating variants, a huge project is bubbling away in the background. The goal is to create a universal coronavirus vaccine designed to generate such broad immunity it will protect people from all currently circulating strains of SARS-CoV-2, as well as any future variants yet to emerge. And there are several compelling candidates in the pipeline.

A new study published in the journal Science is reporting promising results from preclinical studies led by researchers at Caltech. The vaccine utilizes a novel mosaic nanoparticle technology to protect not only against SARS-CoV-2 but also the original SARS, and several common cold coronaviruses.

The experimental vaccine focuses on a particular genera of coronaviruses called betacoronaviruses. These are the most clinically relevant types of coronaviruses to humans, including SARS, MERS, SARS-CoV-2, and two coronaviruses linked to the common cold – OC43 and HKU1.

Pamela Bjorkman, a Caltech researcher leading the project, said generating broad immunity against the entire group of betacoronviruses should offer protection from new viruses that could emerge in the future. And considering we’ve had three dangerous viruses emerge from the betacoronavirus family over the past 20 years, it is crucial to get ahead of what could be the next pandemic.

“What we’re trying to do is make an all-in-one vaccine protective against SARS-like betacoronaviruses regardless of which animal viruses might evolve to allow human infection and spread,” said Bjorkman. “This sort of vaccine would also protect against current and future SARS-CoV-2 variants without the need for updating.”

The Caltech vaccine uses nanoparticle scaffolds to attach a number of different betacoronavirus fragments. Eight different betacoronaviruses are targeted by the vaccine: SARS-CoV-2, and seven other betacoronaviruses currently only circulating in animals but all holding the potential for mutating into a form that could infect humans in the future.

The vaccine does not focus on the traditional coronavirus spike protein, but instead uses viral fragments called receptor-binding domains (RBDs). These are parts of the virus that act as a kind of interface between the spike protein and ACE2 receptors in human cells. RBDs are like the anchor that links the virus up with the human receptor.

This infographic illustrates the new vaccine, composed of RBDs from eight different viruses. The table shows the broad spectrum of SARS-CoV-2 variants and related coronaviruses that the vaccine induces protection against

Wellcome Leap, Caltech, and Merkin Institute

And recent animal studies testing this novel vaccine, dubbed Mosaic-8, have delivered impressive results. Across a number of mouse and primate trials, the researchers found the vaccine successfully protects against most betacoronavirus strains.

Interestingly, the researchers tested the Mosaic-8 design against a nanoparticle solely loaded with a SARS-CoV-2 RBD. When mice were exposed to the original SARS virus, only the animals given the Mosaic-8 vaccine survived. This suggests the combination of eight different antigens does potentially generate broad cross-protective immunity against different types of betacoronaviruses.

“Animals vaccinated with the mosaic-8 nanoparticles elicited antibodies that recognized virtually every SARS-like betacoronavirus strain we evaluated,” noted study co-author Alexander Cohen. “Some of these viruses could be related to the strain that causes the next SARS-like betacoronavirus outbreak, so what we really want would be something that targets this entire group of viruses. We believe we have that.”

Thanks to a big injection of funding from The Coalition for Epidemic Preparedness Innovations (CEPI), Mosaic-8 is on track to move to Phase 1 human trials very soon. Because it is 2022 and most people in the world have either already received a COVID-19 vaccine or been previously infected with SARS-CoV-2, the researchers are first conducting animal studies testing the novel vaccine in previously exposed animals.

“There have already been three serious coronavirus epidemics or pandemics in the twenty-first century – and COVID-19 continues to have a devastating impact on the world’s health, society, and economy,” noted Richard Hatchett, CEO of CEPI. “The creation of vaccines that could provide broad protection against emerging COVID-19 variants and future coronavirus threats would not only help mitigate the damaging effects of another COVID-19-like pandemic, it could also help reduce the time taken and funding spent continually updating vaccine formulations.”

Mosaic-8 is certainly not the only universal coronavirus vaccine currently in development. There are no less than 10 different research groups working with different strategies to produce a coronavirus vaccine that protects from current and future variants.

The US Army, for example, earlier this year reported successful preclinical results testing a unique ferritin nanoparticle with the capacity of holding 24 different coronavirus antigens. This research has already commenced the first phase of human trials and results are expected soon.

The new study was published in the journal Science.

Source: Caltech

appId : '38456013908',

xfbml : true, version : 'v3.3' }); };

(function(d, s, id){ var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) {return;} js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));

Read original article here

Boeing Seeks Redemption as It Readies Starliner for Yet Another Launch Attempt

The Boeing CST-100 Starliner being lifted at the Vertical Integration Facility at Space Launch Complex-41 at Cape Canaveral Space Force Station in Florida.
Photo: NASA/Frank Michaux

Hard to believe, but it’s been nearly two and a half years since Boeing’s first botched test of its Starliner CST-100 spacecraft. Yep, it’s been a minute, so here’s a recap of the past 28 tumultuous months, and how Boeing might finally make good on providing a viable commercial crew vehicle for NASA.

The two previous tests, one in 2019 (Orbital Flight Test-1) and the other last year (Orbital Flight Test-2), did not go well, to say the least. In the first test, the capsule made it to orbit but then glitched and never reached the space station. In the second, stuck valves kept Starliner on the ground. Boeing is developing this capsule under a $4.3 billion contract as part of NASA’s Commercial Crew Program, but it has fallen badly behind schedule. The pressure’s now seriously on.

In preparation for this second attempt at OFT-2, the Starliner capsule is currently sitting atop a United Launch Alliance Atlas V rocket, which is scheduled to launch from Space Launch Complex-41 at Cape Canaveral Space Force Station at 6:54 p.m. EDT on Thursday, May 19. Should all go as planned, the uncrewed CST-100 will dock at the International Space Station on Friday, May 20 at 7:10 p.m. EDT. Starliner OFT-2 is packed with around 500 pounds of cargo (mostly food), and the plan is to return 600 pounds of cargo back to Earth.

Conceptual view of Starliner CST-100 in space.
Image: Boeing

Recent precedent being what it is, this itinerary is hardly a certainty. The problems that have plagued this program have run the gamut, from hardware glitches and software anomalies through to shoddy processes and organizational deficiencies. Boeing’s shortcomings as a NASA partner have been on full display over the past several years and amplified by the accomplishments at SpaceX, NASA’s other commercial crew partner. Elon Musk’s Crew Dragon has been shuttling astronauts to the ISS and returning them home for two years now.

The launch of Boeing’s OFT-1 mission on December 20, 2019 was an early sign that things weren’t quite right. The capsule managed to reach space, but a software automation glitch caused the spacecraft to burn excess fuel, preventing it from reaching its target—the ISS. A subsequent investigation implicated a faulty Mission Elapsed Timer, which caused timings on Starliner and the rocket to go out of sync. Starliner miscalculated its location in space as a result, triggering the unfortunate fuel burn. Investigators also uncovered a coding error that could’ve led to an unsafe service module separation sequence. As if that weren’t enough, space-to-ground communications were unexpectedly lost during the OFT-1 test.

The botched test led an independent NASA-Boeing review team to issue 80 recommendations to Boeing, a lengthy to-do list that included improved testing and modeling, new development requirements, software updates, organizational changes, and operations tweaks. The ensuing effort to address these recommendations resulted in a 1.5-year delay to the Starliner program.

By August 3, 2021, Boeing was ready to perform the second test of Starliner, the OFT-2 mission, but the Atlas V rocket never left the launch pad owing to “unexpected valve position indications” in the capsule’s propulsion system. During the countdown, 13 of 24 oxidizer valves, which “connect to thrusters that enable abort and in-orbit maneuvering,” got stuck in the closed position, forcing the team to abort the launch and return the capsule to the Vertical Integration Facility for closer inspection.

Boeing engineers attending to Starliner after the failed attempt to launch in August 2021.
Photo: Boeing

Engineers later determined that moisture somehow got onto the dry side of the oxidation valves, causing nitric acid to form, and that friction from the ensuing corrosion caused the valves to get stuck. Engineers blamed the humid Florida air for this unwanted moisture.

At a media teleconference on May 3, Steve Stich, manager for NASA’s Commercial Crew Program, said the issue “has been closed out” and that OFT-2 is once again ready to proceed. “It’s been a hard eight months, I would say, but very fulfilling in that we’ve resolved the problem with the oxidizer isolation valve,” he said.

Michelle Parker, vice president and deputy general manager for Space and Launch at Boeing, told reporters that the “spacecraft looks great” and it’s “performing great.” Boeing engineers were able to narrow down the root cause and implement measures to prevent a repeat, she explained. Parker said the team chose not to redesign the valves but instead added sealant and other components to keep moisture away. By “sealing the ambient moisture path,” she said, the team is hoping to avoid a recurrence. “If you eliminate moisture from the valve, you eliminate the [chemical] reaction,” she said. The ground team is now cycling the valves every couple of days to ensure functionality, Parker added.

When asked if another failed test would trigger the end of the NASA-Boeing commercial crew contract, Joel Montalbano, manager of NASA’s ISS program, said the space agency will continue to work with Boeing on the project and that no intention exists to stop now. “I suspect that we’ll learn from the test flight,” and then “go fly the crewed flight and then fly the post-certification missions,” he told reporters.

Indeed, a successful OFT-2 mission would set the stage for OFT-3—a crewed Starliner mission to the ISS. “We understand that we’re going to learn a lot from OFT-2, and that will dictate the schedule moving forward, but we have a target [to launch a crewed mission] at the end of this year,” Mark Nappi, Boeing program manager for the CST-100 Starliner mission, said at the May 3 press conference.

The issue with the valves, it would appear, is not over. Boeing is currently mulling the possibility of redesigning the propulsion valves. “A valve redesign is definitely on the table,” Nappi told reporters this past Wednesday. “Once we get all the information that we need, we’ll make that decision.” And as reported in Reuters, Boeing and Aerojet Rocketdyne are currently squabbling over who’s to blame for the faulty valves. Aerojet Rocketdyne and its lawyers are claiming that a cleaning chemical used by Boeing during ground tests caused the problem, a claim that Boeing denies, according to Reuters. Boeing’s acknowledgement of a potential valve redesign and its blame-game with Aerojet Rocketdyne are bad looks just before the OFT-2 launch.

A crewed Starliner test launch later this year would be grand, but we’d best not get ahead of ourselves. All eyes will be on Space Launch Complex-41 on May 19, in what’s becoming one of the most anticipated and pressure-packed launches of the year.

Read original article here

1st private astronaut mission to space station readies for launch

The International Space Station photographed by Expedition 56 crew members from a Soyuz spacecraft after undocking, October 4, 2018. (NASA/Roscosmos via Reuters)

Estimated read time: 4-5 minutes

HOUSTON — The International Space Station is set to become busier than usual this week when its crew welcomes aboard four new colleagues from Houston-based startup Axiom Space, the first all-private astronaut team ever flown to the orbiting outpost.

The launch is being hailed by the company, NASA and other industry players as a turning point in the latest expansion of commercial space ventures collectively referred to by insiders as the low-Earth orbit economy, or “LEO economy” for short.

Weather permitting, Axiom’s four-man team will lift off on Friday at the earliest from NASA’s Kennedy Space Center in Florida, riding atop a Falcon 9 rocket furnished and flown by Elon Musk’s commercial space launch venture SpaceX.

The launch was initially scheduled for Wednesday. An Axiom spokesperson said on Monday the delay would give SpaceX more time to complete pre-launch processing work.

If all goes smoothly, the quartet led by retired NASA astronaut Michael Lopez-Alegria would arrive at the space station about 28 hours later as their SpaceX-supplied Crew Dragon capsule docks at ISS some 250 miles (400 km) above Earth.

Lopez-Alegria, 63, is the Spanish-born mission commander and Axiom’s vice president of business development. He is set to be joined by Larry Connor, a real estate and technology entrepreneur and aerobatics aviator from Ohio designated as the mission pilot. Connor is in his 70s but the company did not provide his precise age.

Rounding out the Ax-1 team are investor-philanthropist and former Israeli fighter pilot Eytan Stibbe, 64, and Canadian businessman and philanthropist Mark Pathy, 52, both serving as mission specialists. Stibbe is set to become the second Israeli in space, after Ilan Ramon, who perished with six NASA crewmates in the 2003 space shuttle Columbia disaster.

The Ax-1 crew may appear to have a lot in common with many of the wealthy passengers taking suborbital rides lately aboard the Blue Origin and Virgin Galactic services offered by billionaires Jeff Bezos and Richard Branson, respectively. But Axiom executives said their mission is more substantive.

“We are not space tourists,” Lopez-Alegria said during a recent news briefing, adding that the Axiom team has undergone extensive astronaut training with both NASA and SpaceX and will be performing meaningful biomedical research.

‘Many beginnings’

“It is the beginning of many beginnings for commercializing low-Earth orbit,” Axiom’s co-founder and executive chairman, Kam Ghaffarian, told Reuters in an interview. “We’re like in the early days of the internet, and we haven’t even imagined all the possibilities, all the capabilities, that we’re going to be providing in space.”

The so-called Ax-1 team will be carrying equipment and supplies for 26 science and technology experiments to be conducted before they are slated to leave orbit and return to Earth 10 days after launch. These include research on brain health, cardiac stem cells, cancer and aging as well as a technology demonstration to produce optics using the surface tension of fluids in microgravity, company executives said.

Launched to orbit in 1998, ISS has been continuously occupied since 2000 under a U.S.-Russian-led partnership including Canada, Japan and 11 European countries.

While the space station has hosted visits by civilian visitors from time to time, the Ax-1 mission will mark the first all-commercial team of astronauts to use ISS for its intended purpose as an orbiting laboratory.

They will be sharing the weightless workspace alongside seven regular crew members of the ISS — three U.S. astronauts, a German astronaut and three Russian cosmonauts.

Axiom said it has contracted with SpaceX to fly three more missions to orbit over the next two years. NASA selected Axiom in 2020 to design and develop a new commercial wing to the space station, which currently spans the approximate size of a football field. Flight hardware for the first Axiom module is currently undergoing fabrication, the company said.

Plans call for eventually detaching the Axiom modules from the rest of the outpost when ISS is ready for retirement, around 2030, leaving the smaller Axiom station in orbit as a commercial-only platform, Ghaffarian said.

Other private operators are expected to place their own stations in orbit once ISS is decommissioned.

As Kathy Lueders, associate NASA administrator for space operations, described Axiom’s role on a recent teleconference with reporters, “This is going to be an important partnership going forward.”

Related Stories

More stories you may be interested in

Read original article here

South Africa readies hospitals as Omicron variant drives new COVID-19 wave

JOHANNESBURG, Dec 6 (Reuters) – South Africa is preparing its hospitals for more admissions, as the Omicron coronavirus variant pushes the country into a fourth wave of COVID-19 cases, President Cyril Ramaphosa said on Monday.

Omicron was first detected in southern Africa last month and has triggered global alarm as governments fear another surge in infections. read more

South Africa’s daily infections surged last week to more than 16,000 on Friday from roughly 2,300 on Monday.

Register now for FREE unlimited access to reuters.com

Register

Ramaphosa said in a weekly newsletter that Omicron appeared to be dominating new cases in most of the country’s nine provinces and urged more people to get vaccinated against COVID-19.

“South Africa now has sufficient supplies of vaccines, … vaccination is essential for our economic recovery because as more people are vaccinated more areas of economic activity will be opened up,” he said.

The government would soon convene the National Coronavirus Command Council to review the state of the pandemic and decide whether further measures are needed to keep people safe, Ramaphosa said.

Scientists in South Africa and other countries are racing to establish whether Omicron is more contagious, causes more severe disease and is more resistant to existing vaccines.

But some anecdotal accounts from doctors and experts in South Africa are reassuring, suggesting that many infections it causes are mild. read more

“We are keeping a close eye on the rates of infection and hospitalisation,” Ramaphosa said.

Register now for FREE unlimited access to reuters.com

Register

Reporting by Alexander Winning
Editing by Promit Mukherjee & Simon Cameron-Moore

Our Standards: The Thomson Reuters Trust Principles.

Read original article here

Hedge fund CEO readies Senate bid despite Oz announcement

“The Oz candidacy has done nothing to dampen the enthusiasm for a prospective McCormick candidacy,” said Mike DeVanney, a partner at the Pennsylvania-based strategy firm ColdSpark, who is serving as an adviser to McCormick.

McCormick is holding meetings in Philadelphia this week and in Pittsburgh next week, DeVanney confirmed, talking about his plans in an effort to build broad support ahead of a campaign announcement. One event is taking place at the Union League of Philadelphia, an upscale private club in the city, according to two sources.

“He is inching closer to a run,” said Jim Schultz, who was previously a White House lawyer for former President Donald Trump and general counsel to former Pennsylvania GOP Gov. Tom Corbett. “Dave’s the perfect candidate for this and I’ve been encouraging him to run. He is a seventh-generation Pennsylvanian, he spent time across Pennsylvania, he went to high school here, he went to grade school here, he played sports here, he got nominated to West Point from here.”

McCormick’s name has been floated for weeks as a possible candidate in the Senate race, but until recently it was unclear among state GOP insiders how seriously he was looking at a campaign. Several Pennsylvania Republicans, including those who have spoken with McCormick or his advisers, now believe it is all but certain that he will jump in.

The fact that McCormick is taking steps to launch a campaign shows that Oz, a self-funder with millions of followers on social media, is not clearing the field. It also suggests that many party leaders and activists are still shopping around for a candidate.

“It’s going to be a very, very interesting 30 to 60 days here in Republican Pennsylvania politics,” said Sam DeMarco, chair of the Allegheny County Republican Party, who spoke with McCormick recently. He called him an “extremely impressive individual”: “I talked to him about his experience here as a CEO of a local company … and we talked about his success at Bridgewater.”

Christine Toretti, the national committeewoman for the Pennsylvania Republican Party and a friend of McCormick, said party activists seem to be “calming down” in the aftermath of the Oz announcement and taking a “more deliberate look at what is possibly on the horizon.”

“It looks like David is going to get in, it certainly seems that way,” Toretti said. “And I believe that people now are taking a breath, they’re looking at him and looking at his credentials and getting excited about it. The Oz thing is not a done deal.”

McCormick is a Gulf War veteran who served as the Treasury undersecretary for international affairs in George W. Bush’s administration. He is married to former Trump deputy national security adviser Dina Powell.

Greg Manz, a former spokesperson for the Pennsylvania GOP who worked on Trump’s 2016 and 2020 campaigns, said it is “extremely encouraging that David McCormick is diligently taking the political temperature of a Senate run,” noting that he would amass “the war chest needed to keep this Pennsylvania Senate seat red.”

Dan Meuser, a Pennsylvania congressman, tweeted Wednesday that “A lot of people hoping Dave McCormick runs for Senate. Dave is a great American who grew up in my district. Dave would be an America First/PA First Senator for and FROM PENNSYLVANIA!!”

Top Republicans in D.C. appear to be comfortable with either Oz or McCormick receiving the nomination in Pennsylvania and believe that either candidate could win the seat, according to a GOP source involved in Senate races.

Real estate developer Jeff Bartos and Carla Sands, a former ambassador to Denmark under Trump, are also seeking the Republican Senate nomination.

While both Oz and McCormick are relocating to Pennsylvania to run for Senate, McCormick’s ties to the state span several generations. He moved away from the state as an adult.

McCormick, who most recently lived in Connecticut, recently purchased a house in Allegheny County, DeVanney said, and also owns a family farm in Bloomsburg.

Oz, whose campaign has said he moved from New Jersey to his in-laws’ home in Bryn Athyn in the past year, attended the University of Pennsylvania for medical and business school and was born in Ohio.

McCormick was born in Washington County, in the southwestern part of the state, raised further east in Columbia County, and later returned to the Pittsburgh area as a business leader — serving as CEO of software company FreeMarkets, and later president of Ariba after it purchased the company.

His father, who served as president of Bloomsburg University, worked in state government as chancellor of the Pennsylvania State System of Higher Education. McCormick lived in the D.C. area while working in the George W. Bush administration.

In addition to Schultz, political strategist and former Trump campaign adviser David Urban is also helping McCormick launch his campaign, talking to potential supporters and offering advice as McCormick navigates the state.



Read original article here